New Approaches and Treatment Combinations for the Management of Chronic Myeloid Leukemia

Current treatment of chronic myeloid leukemia (CML) with tyrosine kinase inhibitors (TKI) is effective in many patients, but is not curative and frequently limited by intolerance or resistance. Also, treatment free remission is a novel option for CML patients and requires reaching a deep molecular r...

Descripción completa

Detalles Bibliográficos
Autores principales: Westerweel, Peter E., te Boekhorst, Peter A. W., Levin, Mark-David, Cornelissen, Jan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691769/
https://www.ncbi.nlm.nih.gov/pubmed/31448223
http://dx.doi.org/10.3389/fonc.2019.00665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691769/
https://www.ncbi.nlm.nih.gov/pubmed/31448223
http://dx.doi.org/10.3389/fonc.2019.00665

Ejemplares similares